Interleukin-1 Receptor Antagonist and Insulin Sensitivity

Clinical trial NCT00928876 · UNKNOWN

Trial details

NCT number

NCT00928876

Sponsor

Radboud University Medical Center

Status

UNKNOWN

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2009-06-01

Primary completion

2010-03-01

Enrollment

12

View on ClinicalTrials.gov